Exploring Current ME/CFS and Long COVID Clinical Trials on National Clinical Trials Day
May 20 is National Clinical Trials Day! When conducting clinical trials, researchers test how interventions (like behavioral changes, drugs, or medical devices) affect people. Usually, researchers carefully choose who takes […]
Breaking News: FDA clears Ampligen to start a clinical trial in Long Covid
A decade after the U.S. Food and Drug Administration (FDA) did not approve Ampligen (rintatolimod) for the treatment of ME/CFS, this antiviral and immuno-modulator drug is getting a rare second chance. […]
Signature Event Summary — Long Covid: Research, Policy and Economic Impact
As part of our efforts via the Solve Long Covid Initiative, we’ve partnered with the Global Interdependence Center on a year-long webinar and conference series exploring the pandemic’s long-term healthcare, […]
AIM ImmunoTech Announces Update on Ampligen Long Covid Development Program
Today, AIM ImmunoTech, an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19, provided an update […]
Ampligen: A General Overview and the Plan for ME/CFS & Long Covid
For the second installment in our clinical diagnostics and treatments webinar series, Solve M.E. welcomes two leaders from bio-pharma company AIM ImmunoTech to discuss their plans for clinical studies of […]
